
Sign up to save your podcasts
Or


Send us Fan Mail
What if one of the biggest sources of diagnostic variability in prostate cancer isn’t the pathologist—but the stain we’ve trusted for decades?
In this episode, I speak with Professor Ingid Carlbom, founder of CADESS.AI, about a different way to approach prostate cancer grading—by rethinking staining, segmentation, and AI decision support from the ground up. We explore why 30–40% interobserver variability persists in Gleason grading and how optimized stains combined with explainable AI can significantly reduce that uncertainty.
Ingrid shares her journey from applied mathematics and computer science into pathology, the skepticism she faced in 2008, and why CADESS.AI chose not to “optimize H&E,” but instead developed a Picrosirius red + hematoxylin stain designed specifically for computational pathology. We discuss how grading at the gland and cellular level improves reproducibility, why explainability matters for trust, and what it really takes to build both stain and software as a single diagnostic workflow.
This conversation challenges long-held assumptions—and asks whether improving data quality should come before building smarter algorithms.
Highlights:
Resources from This Episode
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!
By Aleksandra Zuraw, DVM, PhD5
77 ratings
Send us Fan Mail
What if one of the biggest sources of diagnostic variability in prostate cancer isn’t the pathologist—but the stain we’ve trusted for decades?
In this episode, I speak with Professor Ingid Carlbom, founder of CADESS.AI, about a different way to approach prostate cancer grading—by rethinking staining, segmentation, and AI decision support from the ground up. We explore why 30–40% interobserver variability persists in Gleason grading and how optimized stains combined with explainable AI can significantly reduce that uncertainty.
Ingrid shares her journey from applied mathematics and computer science into pathology, the skepticism she faced in 2008, and why CADESS.AI chose not to “optimize H&E,” but instead developed a Picrosirius red + hematoxylin stain designed specifically for computational pathology. We discuss how grading at the gland and cellular level improves reproducibility, why explainability matters for trust, and what it really takes to build both stain and software as a single diagnostic workflow.
This conversation challenges long-held assumptions—and asks whether improving data quality should come before building smarter algorithms.
Highlights:
Resources from This Episode
Support the show
Get the "Digital Pathology 101" FREE E-book and join us!

321 Listeners

124 Listeners

504 Listeners

756 Listeners

583 Listeners

818 Listeners

306 Listeners

343 Listeners

125 Listeners

337 Listeners

21 Listeners

141 Listeners

367 Listeners

16 Listeners

152 Listeners